Vukasin Jovanovic

Dr. Vukasin Jovanovic

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2022 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
CTCarlos Tristan
Carlos Tristan
HHHyenjong Hong
Hyenjong Hong
YJYogita Jethmalani
Yogita Jethmalani
YCYu Chen
Yu Chen
CWClaire Weber
Claire Weber
ISIlyas Singeç
Ilyas Singeç

13 July 2023 in Stem Cell Reports
Verified
Journal Article
Open access
VJVukasin Jovanovic
Vukasin Jovanovic
CWClaire Weber
Claire Weber
JSJaroslav Slamecka
Jaroslav Slamecka
SRSeungmi Ryu
Seungmi Ryu
PCPei-Hsuan Chu
Pei-Hsuan Chu
ISIlyas Singeç
Ilyas Singeç
Human gliogenesis remains poorly understood, and derivation of astrocytes from human pluripotent stem cells (hPSCs) is inefficient and cumbersome. Here, we report controlled glial differentiation from hPSCs that bypasses neurogenesis, which otherwise precedes astrogliogenesis during brain development and in vitro differentiation. hPSCs were first differentiated into radial glial cells (RGCs) resembling resident RGCs of the fetal telencephalon, and modulation of specific cell signaling pathways resulted in direct and stepwise induction of key astroglial markers (NFIA, NFIB, SOX9, CD44, S100B, glial fibrillary acidic protein [GFAP]). Transcriptomic and genome-wide epigenetic mapping and single-cell analysis confirmed RGC-to-astrocyte differentiation, obviating neurogenesis and the gliogenic switch. Detailed molecular and cellular characterization experiments uncovered new mechanisms and markers for human RGCs and astrocytes. In summary, establishment of a glia-exclusive neural lineage progression model serves as a unique serum-free platform of manufacturing large numbers of RGCs and astrocytes for neuroscience, disease modeling (e.g., Alexander disease), and regenerative medicine.

30 November 2020 in Brain
Verified
Journal Article
Open access
PDF file
ZVZagorka Vitic
Zagorka Vitic
HSHazem Safory
Hazem Safory
VJVukasin Jovanovic
Vukasin Jovanovic
YSYael Sarusi
Yael Sarusi
ASAlexandra Stavsky
Alexandra Stavsky
CBClaude Brodski
Claude Brodski
Whone et al. (2019) recently reported a randomized clinical trial of intermittent intraputamenal glial cell line-derived neurotrophic factor (GDNF) in Parkinson’s disease. Whone et al. achieved an important milestone by demonstrating that convection-enhanced delivery is an efficient and safe way for long-term intraparenchymal drug application. GDNF was well tolerated and caused a significant increase in 18F-DOPA uptake. However, the study failed to reach its clinical end points.

11 December 2023 in Biofabrication
Verified
Journal Article
Open access
PDF file
SRSeungmi Ryu
Seungmi Ryu
CWClaire Weber
Claire Weber
PCPei-Hsuan Chu
Pei-Hsuan Chu
BEBen Ernest
Ben Ernest
VJVukasin Jovanovic
Vukasin Jovanovic
ISIlyas Singeç
Ilyas Singeç
Embryoid bodies (EBs) and self-organizing organoids derived from human pluripotent stem cells (hPSCs) recapitulate tissue development in a dish and hold great promise for disease modeling and drug development. However, current protocols are hampered by cellular stress and apoptosis during cell aggregation, resulting in variability and impaired cell differentiation. Here, we demonstrate that EBs and various organoid models (e.g., brain, gut, kidney) can be optimized by using the small molecule cocktail named CEPT (chroman 1, emricasan, polyamines, trans-ISRIB), a polypharmacological approach that ensures cytoprotection and cell survival. Application of CEPT for just 24 h during cell aggregation has long-lasting consequences affecting morphogenesis, gene expression, cellular differentiation, and organoid function. Various qualification methods confirmed that CEPT treatment enhanced experimental reproducibility and consistently improved EB and organoid fitness as compared to the widely used ROCK inhibitor Y-27632. Collectively, we discovered that stress-free cell aggregation and superior cell survival in the presence of CEPT are critical quality control determinants that establish a robust foundation for bioengineering complex tissue and organ models.

27 August 2024 in Endocrinology
Verified
Journal Article
Open access
PDF file
SYShu Yang
Shu Yang
LZLi Zhang
Li Zhang
KKKamal Khan
Kamal Khan
JTJameson Travers
Jameson Travers
RHRuili Huang
Ruili Huang
MXMenghang Xia
Menghang Xia
There has been an alarming trend toward earlier puberty in girls, suggesting the influence of an environmental factor(s). As the reactivation of the reproductive axis during puberty is thought to be mediated by the hypothalamic neuropeptides kisspeptin and gonadotropin-releasing hormone (GnRH), we asked whether an environmental compound might activate the kisspeptin (KISS1R) or GnRH receptor (GnRHR). We used GnRHR or KISS1R-expressing HEK293 cells to screen the Tox21 10K compound library, a compendium of pharmaceuticals and environmental compounds, for GnRHR and KISS1R activation. Agonists were identified using Ca2+ flux and phosphorylated extracellularly regulated kinase (p-ERK) detection assays. Follow-up studies included measurement of genes known to be upregulated upon receptor activation using relevant murine or human cell lines and molecular docking simulation. Musk ambrette was identified as a KISS1R agonist, and treatment with musk ambrette led to increased expression of Gnrh1 in murine and human hypothalamic cells and expansion of GnRH neuronal area in developing zebrafish larvae. Molecular docking demonstrated that musk ambrette interacts with the His309, Gln122, and Gln123 residues of the KISS1R. A group of cholinergic agonists with structures similar to methacholine was identified as GnRHR agonists. When applied to murine gonadotrope cells, these agonists upregulated Fos, Jun, and/or Egr1. Molecular docking revealed a potential interaction between GnRHR and 5 agonists, with Asn305 constituting the most conservative GnRHR binding site. In summary, using a Tox21 10K compound library screen combined with cellular, molecular, and structural biology techniques, we have identified novel environmental agents that may activate the human KISS1R or GnRHR.

4 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
CTCarlos Tristan
Carlos Tristan
POPinar Ormanoglu
Pinar Ormanoglu
JSJaroslav Slamecka
Jaroslav Slamecka
CMClaire Malley
Claire Malley
PCPei-Hsuan Chu
Pei-Hsuan Chu
ISIlyas Singeç
Ilyas Singeç
Efficient translation of human induced pluripotent stem cells (hiPSCs) depends on implementing scalable cell manufacturing strategies that ensure optimal self-renewal and functional differentiation. Currently, manual culture of hiPSCs is highly variable and labor-intensive posing significant challenges for high-throughput applications. Here, we established a robotic platform and automated all essential steps of hiPSC culture and differentiation under chemically defined conditions. This streamlined approach allowed rapid and standardized manufacturing of billions of hiPSCs that can be produced in parallel from up to 90 different patient-and disease-specific cell lines. Moreover, we established automated multi-lineage differentiation to generate primary embryonic germ layers and more mature phenotypes such as neurons, cardiomyocytes, and hepatocytes. To validate our approach, we carefully compared robotic and manual cell culture and performed molecular and functional cell characterizations (e.g. bulk culture and single-cell transcriptomics, mass cytometry, metabolism, electrophysiology, Zika virus experiments) in order to benchmark industrial-scale cell culture operations towards building an integrated platform for efficient cell manufacturing for disease modeling, drug screening, and cell therapy. Combining stem cell-based models and non-stop robotic cell culture may become a powerful strategy to increase scientific rigor and productivity, which are particularly important during public health emergencies (e.g. opioid crisis, COVID-19 pandemic).